Table 1 Patient characteristics.
Demographics | Scar Group (n = 8) | Control Group (n = 20) | t | χ2 | P |
|---|---|---|---|---|---|
Mean age (yr) | 42.3 ± 6.6 | 38.4 ± 5.3 | −1.64 | 0.11 | |
BMI (kg/m2) | 24.1 ± 2.4 | 22.2 ± 2.3 | −1.95 | 0.06 | |
Diabetes | 0 (0.0%) | 1 (5.0%) | – | 1.00 | |
Smokers | 1 (12.5%) | 0 (0.0%) | – | 0.29 | |
NAC | 1 (12.5%) | 1 (5.0%) | – | 0.50 | |
PR | 0 (0.0%) | 0 (0.0%) | – | ||
Histology | – | 0.79 | |||
DCIS | 0 (0.0%) | 2 (10.0%) | |||
LCIS | 0 (0.0%) | 1 (5.0%) | |||
IDC | 7 (87.5%) | 15 (75.0%) | |||
ILC | 1 (12.5%) | 0 (0.0%) | |||
mucinous | 0 (0.0%) | 1 (5.0%) | |||
Medullary | 0 (0.0%) | 1 (5.0%) | |||
Histological grade | – | 0.27 | |||
1 | 2 (25.0%) | 1 (5.0%) | |||
2 | 4 (50.0%) | 7 (35.0%) | |||
3 | 2 (25.0%) | 9 (45.0%) | |||
In situ carcinoma | 0 (0.0%) | 3 (15.0%) | |||
pTNM stage | – | 0.38 | |||
0 | 0 (0.0%) | 3 (15.0%) | |||
I | 2 (25.0%) | 3 (15.0%) | |||
II | 5 (62.5%) | 14 (70.0%) | |||
III | 1 (12.5%) | 0 (0.0%) | |||
Molecular subtype | – | 0.76 | |||
Luminal A | 2 (25.0%) | 6 (30.0%) | |||
Luminal B1 | 4 (50.0%) | 5 (25.0%) | |||
Luminal B2 | 0 (0.0%) | 3 (15.0%) | |||
HER-2 overexpression | 1 (12.5%) | 2 (10.0%) | |||
Triple negative | 1 (12.5%) | 4 (20.0%) |
